Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,167 | 569 | 98.3% |
| Education | $180.70 | 26 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,648 | 56 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,265 | 82 | $0 (2023) |
| PFIZER INC. | $939.32 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $650.80 | 33 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $495.53 | 31 | $0 (2023) |
| Novo Nordisk Inc | $465.99 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $462.12 | 21 | $0 (2024) |
| Allergan, Inc. | $364.95 | 23 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $351.14 | 39 | $0 (2023) |
| Amarin Pharma Inc. | $291.51 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,106 | 49 | AstraZeneca Pharmaceuticals LP ($433.27) |
| 2023 | $1,231 | 75 | Kowa Pharmaceuticals America, Inc. ($199.00) |
| 2022 | $978.87 | 57 | Novo Nordisk Inc ($135.50) |
| 2021 | $1,108 | 77 | AstraZeneca Pharmaceuticals LP ($191.58) |
| 2020 | $1,098 | 67 | Janssen Pharmaceuticals, Inc ($163.68) |
| 2019 | $1,245 | 62 | AstraZeneca Pharmaceuticals LP ($262.35) |
| 2018 | $1,641 | 68 | Novartis Pharmaceuticals Corporation ($369.09) |
| 2017 | $1,941 | 140 | Daiichi Sankyo Inc. ($268.69) |
All Payment Transactions
595 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: PAIN | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: DIABETES | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $126.02 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Neurology | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $99.98 | General |
| Category: Durable Pump | ||||||
| 07/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,480 | 3,420 | $493,854 | $178,461 |
| 2022 | 20 | 1,549 | 3,627 | $509,740 | $183,133 |
| 2021 | 21 | 1,744 | 4,104 | $548,724 | $198,872 |
| 2020 | 24 | 2,097 | 4,926 | $636,561 | $217,901 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 283 | 1,046 | $207,108 | $55,037 | 26.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 130 | 419 | $52,375 | $23,661 | 45.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 115 | 160 | $40,000 | $21,166 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 224 | $58,240 | $17,054 | 29.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 127 | 470 | $35,250 | $13,949 | 39.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 212 | $26,565 | $12,911 | 48.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 119 | 307 | $26,285 | $11,779 | 44.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 100 | 136 | $17,204 | $8,400 | 48.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $10,782 | $3,978 | 36.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 45 | $5,805 | $3,233 | 55.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 66 | $1,914 | $1,876 | 98.0% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Office | 2023 | 23 | 25 | $3,750 | $1,540 | 41.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 14 | 14 | $2,800 | $1,428 | 51.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 134 | $1,340 | $1,126 | 84.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 61 | $1,747 | $580.72 | 33.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 21 | 21 | $1,071 | $459.90 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 25 | $1,440 | $234.52 | 16.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 22 | $178.00 | $48.40 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 297 | 1,142 | $226,116 | $60,516 | 26.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 134 | 181 | $45,250 | $27,475 | 60.7% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 174 | 745 | $55,875 | $24,594 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 173 | $44,980 | $14,217 | 31.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 95 | 229 | $28,670 | $12,400 | 43.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 101 | 220 | $27,500 | $11,568 | 42.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 121 | 318 | $26,958 | $9,469 | 35.1% |
About Dr. David Provaznik, DO
Dr. David Provaznik, DO is a Family Medicine healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245267624.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Provaznik, DO has received a total of $10,348 in payments from pharmaceutical and medical device companies, with $1,106 received in 2024. These payments were reported across 595 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($10,167).
As a Medicare-enrolled provider, Provaznik has provided services to 6,870 Medicare beneficiaries, totaling 16,077 services with total Medicare billing of $778,367. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Wheelersburg, OH
- Active Since 06/28/2006
- Last Updated 02/12/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245267624
Products in Payments
- XARELTO (Drug) $1,131
- FARXIGA (Drug) $644.81
- ENTRESTO (Drug) $607.96
- JARDIANCE (Drug) $488.56
- ELIQUIS (Drug) $381.65
- BREZTRI (Drug) $307.24
- AIRSUPRA (Drug) $306.48
- Vascepa (Drug) $291.51
- UBRELVY (Drug) $246.94
- VRAYLAR (Drug) $227.93
- NURTEC ODT (Drug) $214.38
- TOUJEO (Drug) $211.67
- Tresiba (Drug) $189.70
- AUSTEDO (Drug) $177.77
- SEGLENTIS (Drug) $176.15
- SOLIQUA 100/33 (Biological) $175.17
- TRELEGY ELLIPTA (Drug) $171.95
- XIFAXAN (Drug) $160.06
- Movantik (Drug) $155.31
- Livalo (Drug) $152.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wheelersburg
Mr. James Mcginnis, Do, DO
Family Medicine — Payments: $19,090
Jerod Walker, Do, DO
Family Medicine — Payments: $8,192
Zachary Underwood, Do, DO
Family Medicine — Payments: $6,464
Dr. Kemmely Hochstetler, M.d, M.D
Family Medicine — Payments: $2,429
Dr. J Hernandez, Md, MD
Family Medicine